{"id":"W2976926951","doi":"10.1016/j.afos.2019.09.003","title":"Osteoporosis liaison service in Japan","year":2019,"lang":"en","type":"review","venue":"Osteoporosis and Sarcopenia","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eli Lilly Japan; Pfizer Japan; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Astellas Foundation for Research on Metabolic Disorders; Taisho Toyama Pharmaceutical Company; Astellas Pharma; Mochida Pharmaceutical Company; Asahi Kasei Pharma Corporation; Ono Pharmaceutical; Eisai; Teijin Pharma; Daiichi-Sankyo; Eisai Canada; Takeda Pharmaceutical Company","keywords":"Medicine; Osteoporosis; Fragility fracture; Service (business); Secondary prevention; Fracture (geology); Fragility; Primary prevention; Physical therapy; Internal medicine; Bone mineral; Engineering; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001272552,0.00115426,0.005525937,0.001039766,0.0002051445,0.0002130341,0.0005205406,0.001340163,0.001031123],"category_scores_gemma":[0.0001898136,0.0009277753,0.0006652555,0.00187907,0.000142294,0.000266879,0.0005587361,0.001965807,0.002104015],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004671842,"about_ca_system_score_gemma":0.001789912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001517753,"about_ca_topic_score_gemma":0.001099703,"domain_scores_codex":[0.9933863,0.0003935137,0.001995974,0.001694565,0.0009989338,0.001530691],"domain_scores_gemma":[0.9961457,0.000480185,0.0005722835,0.00150814,0.0002711762,0.001022543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001240576,0.0002486147,0.00137879,0.07580882,0.00008389197,0.00005514521,0.0004357797,9.16706e-8,0.00001046444,0.00002872953,0.002621444,0.9192042],"study_design_scores_gemma":[0.00250566,0.0007195642,0.002314143,0.0278757,0.0009737659,0.0003301392,0.0003968126,0.00001454037,0.000006043504,0.000008123623,0.9640052,0.0008502731],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003486296,0.9849133,1.921498e-7,0.0008554025,0.0003734364,0.004749999,0.0001718182,0.00009586457,0.005353704],"genre_scores_gemma":[0.0003784903,0.9904543,0.000393375,0.001397691,0.0002513853,0.0005453004,0.0007360607,0.0002696801,0.005573673],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9613838,"threshold_uncertainty_score":0.9999563,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07736174565727015,"score_gpt":0.3772257575387832,"score_spread":0.2998640118815131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}